Fullscript and ŌURA have forged a strategic partnership to bring the Oura Ring’s biometric insights directly into Fullscript’s clinical workflow. With the integration of Oura Ring stats into the Fullscript platform, providers can—for the first time—access wearable data, lab results, and patient treatment history in one place, enabling a truly comprehensive, provider-facing view that enables the seamless delivery of whole person care, according to executives at both companies.

“This partnership is a monumental step toward real-time, whole person care,” Fullscript Co-Founder/CEO Kyle Braatz stated. “Oura’s continuous health signals are powerful on their own, but when paired with Fullscript’s clinical insights, lab data, and personalized protocols, they become transformative. Providers can now bring more context to treatment conversations and ongoing care management, allowing for more comprehensive care, all without leaving their existing workflow.”

More than 125,000 providers that use Fullscript will soon be able (for patients who opt in) to view patient sleep, readiness, and activity trend data from the Oura Ring alongside medical history and lab diagnostics. These biometric insights are intended to inform a clinician’s decision-making process and help guide care pathways.

“Continuous, longitudinal health signals, like those captured with Oura Ring, are most powerful when they’re connected to real clinical decision-making,” ŌURA Chief Medical Officer Dr. Ricky Bloomfield commented. “By integrating Oura insights into Fullscript, we’re giving providers a deeper view of how their patients are sleeping, recovering, and responding to daily stressors, so they can spend less time stitching data together and more time delivering proactive, preventive care that benefits individuals, clinicians, and health systems alike.”

For patients, this integration creates a more connected care experience, Fullscript and ŌURA bigwigs claim. With their biometric trends, supplement protocols, and lab results viewable by their provider within one system, patients benefit from a more unified, personalized treatment plan. This consolidation of data helps ensure consistency across care recommendations and strengthens patient engagement by reinforcing how daily habits connect to clinical outcomes.

“Patients don’t just want more data — they want providers who can translate that data into care that feels personal, timely, and relevant to their everyday lives,” Midi Health Co-Founder/CEO Joanna Strober stated. “By bringing Oura’s continuous health signals into Fullscript’s clinical platform and into Midi’s workflows, we can give our patients more tailored treatment plans and more meaningful follow-up, while strengthening each of our platforms’ positions as leaders in a rapidly evolving, data-driven healthcare market.”

Providers on Fullscript can consider Oura data across various scenarios:

• Low Readiness scores may prompt clinicians to have discussions around recovery strategies, modifications to training plans, or stress management techniques.
• Improved sleep metrics may lead to decisions to taper interventions or reinforce healthy routines.
• Activity trends may guide the timing of lifestyle recommendations or lab follow ups. 

The integration will begin rolling out soon, giving Fullscript practitioners the ability to access and act on their patients’ Oura data from directly within the Fullscript platform. In early Q2, Oura Ring will be available for ordering directly through the Fullscript catalog, enabling clinicians to easily incorporate wearables into their care strategies. 

Founded in 2011, Fullscript is a healthcare platform powering whole person care. With a full suite of clinical tools that make it easier for practices to deliver personalized care more efficiently and effectively, Fullscript has helped more than 125,000 providers and 10 million patients with seamless access to high-quality supplements, industry-leading labs, and smart adherence tools.

ŌURA delivers personalized health data, insights, and daily guidance with the Oura Ring, a smart ring designed to help its users live healthier and longer. Guided by a mission to shift healthcare from sick care to prevention, ŌURA supports millions of members worldwide across sleep, activity, stress, readiness, women’s health, and heart health. Scientifically validated against medical gold standards, the lightweight Oura Ring tracks more than 50 health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, and organizations. Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses.

Founded in Finland in 2013, ŌURA maintains its European headquarters in Oulu and U.S. headquarters in San Francisco. ŌURA was last valued at approximately $11 billion—making it the world’s most valuable standalone wearable company.